Showing results (21-30 of 23) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
British Journal of Haematology|September 10, 2023
Polyclonal immunoglobulin recovery in patients with newly diagnosed myeloma receiving maintenance therapy after autologous haematopoietic stem cell transplantation with either carfilzomib, lenalidomide and dexamethasone or lenalidomide alone: Subanalysis of the randomized phase 3 ATLAS trialTadeusz Kubicki, Dominik Dytfeld, Tomasz Wróbel, et al.The Lancet. Haematology|March 14, 2026
Carfilzomib, lenalidomide, and dexamethasone compared with lenalidomide treatment after autologous haematopoietic stem-cell transplantation in patients with multiple myeloma (ATLAS): primary analysis of a randomised, open-label, phase 3 trialDominik Dytfeld, Tomasz Wróbel, Krzysztof Jamroziak, et al.The Lancet. Oncology|January 15, 2023
Carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone as maintenance therapy after autologous stem-cell transplantation in patients with multiple myeloma (ATLAS): interim analysis of a randomised, open-label, phase 3 trialDominik Dytfeld, Tomasz Wróbel, Krzysztof Jamroziak, et al.Pageof 3